TECH insider sale notice: 17,040 shares via Morgan Stanley ($957,849)

Rhea-AI Filing Summary

Form 144 notice for Bio-Techne Corp. (TECH) reports a proposed sale of 17,040 shares of common stock through Morgan Stanley Smith Barney with an aggregate market value of $957,849.07. The filing shows the shares outstanding are 155,549,587 and lists the approximate sale date as 08/25/2025 on NASDAQ. The securities were acquired on 08/25/2025 by exercise of options under a registered plan from the issuer and payment is shown as cash. The filer represents they are not aware of undisclosed material adverse information. Several identifying fields such as the filer name/CIK and issuer address are not provided in the text.

Insights

Securities Analyst

TL;DR: Routine insider sale notice for 17,040 shares; size is immaterial relative to outstanding shares.

This Form 144 documents a proposed sale following an option exercise and cash payment. The aggregate value (~$958k) represents a small fraction of the issuer's reported outstanding shares (155.5 million), indicating the transaction is unlikely to materially affect capital structure or market liquidity. The filing contains basic sale mechanics and broker details but omits the filer identity in the provided text, which limits assessment of insider status or potential signaling.

Corporate Compliance Expert

TL;DR: Filing meets Rule 144 mechanics but missing some identifying details in the provided extract.

The notice shows acquisition by exercise under a registered plan and planned resale through a broker on a single date with cash payment, consistent with standard Rule 144 disclosures. The signature/representation language about lack of undisclosed material information is present. However, the excerpt lacks explicit filer and issuer contact details, which are typically included on a complete Form 144; that omission in the supplied content prevents full compliance verification from this extract alone.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	17040	957849.07	155549587	08/25/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/25/2025	Exercise of options under a registered plan	Issuer			17040	08/25/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Bio-Techne (TECH) report?

It reports a proposed sale of 17,040 common shares through Morgan Stanley Smith Barney with aggregate market value of $957,849.07 and an approximate sale date of 08/25/2025.

How were the shares acquired according to the filing?

The shares were acquired on 08/25/2025 by exercise of options under a registered plan from the issuer, with payment made in cash.

Does the filing identify the broker and exchange?

Yes. The broker is Morgan Stanley Smith Barney LLC and the securities are listed for sale on NASDAQ.

Is the filer identified in the provided content?

No. The supplied extract does not include the filer name or CIK, so the filer’s identity cannot be confirmed from this text.

Does the filing disclose other sales in the past three months?

No. The section for securities sold during the past three months states "Nothing to Report".